Surgical Removal of Carotid Body in Patients With Systolic Heart Failure (FIM)
The aim of the study is to determine safety, tolerability and feasibility of unilateral and bilateral carotid body excision in patients with systolic heart failure and peripheral chemoreceptor hypersensitivity.
Systolic Heart Failure
Peripheral Chemoreceptor Hypersensitivity
Procedure: Carotid body excision
|Study Design:||Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||Surgical Removal of Carotid Body in Patients With Systolic Heart Failure.|
- Peripheral chemosensitivity [ Time Frame: 4 weeks ] [ Designated as safety issue: No ]Ventilatory response to hypoxia using transient inhalation of nitrogen.
|Study Start Date:||August 2012|
|Study Completion Date:||November 2013|
|Primary Completion Date:||November 2013 (Final data collection date for primary outcome measure)|
Experimental: Carotid body excision
Patients undergoing unilateral or bilateral removal of carotid body.
|Procedure: Carotid body excision|
Please refer to this study by its ClinicalTrials.gov identifier: NCT01653821
|Centrum Chorób Serca - Klinika Kardiologii, 4. Wojskowy Szpital Kliniczny|
|Wroclaw, Poland, 50-981|